Status
Conditions
Treatments
About
This study's purpose is to prospectively determine whether topical therapy with an oxidized regenerated cellulose collagen-silver compound is more effective than the current standard of topical antibiotic therapy for care following the removal of an ingrown toenail. Eighty adult patients with ingrown toenails will be recruited. Each patient will randomly be assigned to apply either topical silver sulfadiazine cream (standard antibiotic) or the novel collagen-silver compound to their nail bed daily, following removal of the ingrown portion of nail. Patients will return for follow up visits weekly, until healing has occurred or twelve weeks have passed. Healing will be defined as resolution of drainage and inflammatory changes surrounding the nail border.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patients with immunocompromised states
Cellulitis proximal to the hallux interphalangeal joint or peripheral vascular disease will be excluded
We will define peripheral vascular disease as the absence of one or more pedal pulses or the presence of dystrophic changes to the integument
Primary purpose
Allocation
Interventional model
Masking
80 participants in 2 patient groups
Loading...
Central trial contact
David G Armstrong, DPM, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal